MedTrace Logo

Focal Prostate Radiofrequency Ablation

NCT02294903 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-04-24

No results posted yet for this study

Summary

To assess the early histological outcomes of tissue ablation, adverse events and genitourinary side-effect profile of focal radiofrequency ablation using a coiled bipolar device to treat localized prostate cancer in men with clinically significant prostate cancer.

Conditions

Interventions

PROCEDURE

Coiled Bipolar Radiofrequency Ablation

Radiofrequency ablation by use of bipolar electrodes

Sponsors & Collaborators

  • Trod Medical N.V.

    lead INDUSTRY

Principal Investigators

  • Ahmed U HASHIM, FRCS, PhD · UCLH NHS Foundation Trust

  • Mark EMBERTON, FRCS, MD · Division of Surgery & Interventional Science, UCL

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-04-30
Completion
2018-05-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02294903 on ClinicalTrials.gov